BASKING RIDGE, N.J. (June 30, 2006)—Pharmaceutical services company i3, an Ingenix company, is pleased to announce the appointment of Gregg Dearhammer as president, i3 Statprobe. Dearhammer comes to i3 from Kendle International, where he held a series of positions culminating in his role as global vice president of Biometrics.
"Gregg's experience and management style dovetails well with the i3 organization," said Glenn Bilawsky, CEO of i3. "His expertise, customer focus and passion for quality will enable him to capitalize on the success i3 Statprobe has had to date, and made him the ideal choice to lead that group forward."
About i3 Statprobe
i3 Statprobe is a leader in comprehensive clinical data services. Using compliant and validated systems built on leading-edge technologies, i3 Statprobe's team provides a full range of data and biostatistical services, most notably EDC, for the pharmaceutical and biotechnology industries. i3 Statprobe has led the industry in adopting the latest gold-standard technology, such as Oracle Clinical. i3's staff, with an average of 10 years experience in the pharmaceutical industry, analyzes and reports data in a secure environment that provides the client and project team real-time access to clinical data and information. For more information, visit www.i3statprobe.com.
About i3
i3, a global Ingenix company, provides integrated scientific strategies and solutions throughout the pharmaceutical product lifecycle. It is composed of i3 Statprobe, a leader in comprehensive data services; i3 Research, a therapeutically specialized contract research organization; i3 Drug Safety, engaged in pharmacovigilence and epidemiology; i3 Innovus (formerly i3 Magnifi), delivering the science and solutions to achieve marketplace success; i3 Pharma Resourcing, a world-class staffing partner; and, i3 DLN, providing continuing medical education. i3 helps companies gain sharper insights that lead to better patient care. For more information, visit www.i3global.com. |
